These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12419477)

  • 1. Approach to lipoprotein management in 2001 National Cholesterol Guidelines.
    Grundy SM;
    Am J Cardiol; 2002 Oct; 90(8A):11i-21i. PubMed ID: 12419477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
    Ansell BJ; Watson KE; Fogelman AM
    JAMA; 1999 Dec; 282(21):2051-7. PubMed ID: 10591388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.
    McKenney JM
    Pharmacotherapy; 2003 Sep; 23(9 Pt 2):26S-33S. PubMed ID: 14524636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemia.
    Talbert RL;
    Am J Health Syst Pharm; 2003 Jul; 60(13 Suppl 2):S3-8; quiz S25. PubMed ID: 12901024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of non-HDL cholesterol in risk stratification for coronary artery disease.
    Rana JS; Boekholdt SM; Kastelein JJ; Shah PK
    Curr Atheroscler Rep; 2012 Apr; 14(2):130-4. PubMed ID: 22203405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New features of the National Cholesterol Education Program Adult Treatment Panel III lipid-lowering guidelines.
    Brewer HB
    Clin Cardiol; 2003 Apr; 26(4 Suppl 3):III19-24. PubMed ID: 12708635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the new National Cholesterol Education Program (NCEP) guidelines on patient management.
    Harmel AP; Berra K
    J Am Acad Nurse Pract; 2003 Aug; 15(8):350-60. PubMed ID: 14509100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoproteins and risk for coronary artery disease.
    Ballantyne CM
    Am J Cardiol; 1998 Nov; 82(9A):3Q-12Q. PubMed ID: 9819098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Lipsy RJ
    J Manag Care Pharm; 2003; 9(1 Suppl):2-5. PubMed ID: 14613351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of the Adult Treatment Panel III: the 2001 National Cholesterol Education Program guidelines on the detection, evaluation and treatment of elevated cholesterol in adults.
    Pasternak RC
    Cardiol Clin; 2003 Aug; 21(3):393-8. PubMed ID: 14621453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hypercholesterolaemia in postmenopausal women.
    Davidson MH; Maki KC; Karp SK; Ingram KA
    Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.